The global Liquid Handling System Market is becoming an increasingly important part of modern laboratory infrastructure as pharmaceutical companies, biotechnology firms, research institutions, hospitals, and diagnostic laboratories look for faster and more reliable ways to process samples. From transferring tiny volumes of reagents to preparing thousands of samples for genomic analysis, liquid handling systems help laboratories perform repetitive processes with greater consistency and precision.
According to Kings Research, the global liquid handling system market was valued at USD 4,731.7 million in 2024 and is projected to grow from USD 4,951.7 million in 2025 to USD 7,131.7 million by 2032, registering a CAGR of 5.35% during the forecast period.
The market’s growth is closely connected to the increasing need for high-throughput laboratory operations. Pharmaceutical and biotechnology research generates large volumes of samples that must be handled accurately and repeatedly. Manual pipetting and liquid transfer can become difficult to manage at scale, particularly when experiments involve hundreds or thousands of samples.
This is where automated liquid handling systems are making a significant difference. By combining precision instruments, software, robotics, and laboratory workflows, these systems can reduce repetitive manual work while improving consistency and throughput.
Why Laboratory Automation Is Becoming Essential
Modern life sciences research is moving at a much faster pace than it did a decade ago. Drug discovery programs involve large compound libraries, genomic studies generate enormous quantities of biological samples, and diagnostic laboratories increasingly process high numbers of tests.
In such environments, even a small variation in liquid volume can influence experimental results. A pipetting error may affect an assay, compromise a sample, or require an experiment to be repeated. For laboratories operating under strict timelines, these errors can translate into additional costs and lost productivity.
Liquid handling systems address this challenge by automating repetitive liquid-transfer activities. Depending on the configuration, systems can dispense, dilute, mix, transfer, and distribute liquids across microplates and other laboratory vessels.
The growing emphasis on reproducibility is therefore one of the strongest reasons laboratories are adopting automated solutions. Automation does not eliminate every source of experimental variability, but it can provide a more standardized environment for routine liquid-handling tasks.
Automated Liquid Handling Systems Lead the Market
The market is segmented by type into automated liquid handling systems and manual liquid handling systems. Automated systems accounted for 58.43% of the market in 2024, reflecting the increasing demand for precision, efficiency, and reduced manual intervention.
The automated liquid handling systems segment is projected to reach USD 4,168.5 million by 2032.
The appeal of automation is particularly strong in laboratories conducting repetitive workflows. Once a protocol has been programmed and validated, an automated system can execute repeated liquid transfers with consistent parameters.
This is especially valuable for applications such as next-generation sequencing, polymerase chain reaction preparation, compound screening, cell-based assays, and sample preparation.
However, manual liquid handling continues to have a place in laboratories. Manual pipettes are often useful for smaller laboratories, flexible workflows, low-volume testing, and applications where researchers need direct control over individual samples.
The future laboratory is therefore unlikely to be completely manual or completely automated. Instead, laboratories are increasingly combining manual equipment with automated platforms according to their workload and research requirements.
Automated Workstations Support High-Throughput Research
Among products, automated workstations generated USD 2,044.6 million in revenue in 2024, making them a major component of the market.
Automated workstations bring multiple laboratory functions together in a coordinated environment. Rather than requiring scientists to perform each step separately, a workstation can automate sequences of sample preparation and liquid transfer.
This can be particularly useful for pharmaceutical and biotechnology laboratories where researchers need to process large numbers of samples under standardized conditions.
For example, a drug discovery laboratory may need to prepare thousands of samples before screening compounds against a biological target. An automated workstation can perform repetitive dispensing and plate preparation steps while researchers focus on experimental design, analysis, and interpretation.
The growing adoption of these systems reflects a broader change in laboratory operations: researchers are increasingly spending less time on repetitive physical tasks and more time on activities that require scientific judgment.
Drug Discovery and Development Remains a Major Application
The drug discovery and development segment represents one of the most important application areas for liquid handling systems. Kings Research projects this segment to reach USD 2,625.9 million by 2032.
Drug discovery requires researchers to test large numbers of compounds, biological targets, and experimental conditions. High-throughput screening allows laboratories to evaluate many potential drug candidates more efficiently, but it also creates demanding sample-preparation requirements.
Liquid handling automation can support these workflows by accurately transferring compounds, reagents, and biological samples between plates and other laboratory containers.
The technology can also help researchers standardize experimental protocols. Consistent liquid transfer is particularly important when comparing results across large experimental datasets.
As pharmaceutical companies increase investments in precision medicine, biologics, genomics, and advanced drug discovery approaches, demand for reliable laboratory automation is expected to remain strong.
Genomics and Cancer Research Create New Opportunities
Genomic research is another major area where liquid handling systems are becoming increasingly important. Modern genomic workflows often involve multiple preparation stages, including DNA or RNA extraction, purification, amplification, library preparation, and sequencing.
Many of these processes require precise handling of small liquid volumes. Automation can reduce repetitive manual work and help laboratories process larger numbers of samples.
Cancer research is also generating demand. Researchers increasingly use genomic and molecular techniques to understand tumor biology, identify biomarkers, and investigate potential therapeutic targets.
As genomic testing becomes more accessible, laboratories need infrastructure capable of processing increasing numbers of samples without compromising quality. Liquid handling systems can become an important part of this infrastructure.
Integration With Robotics and Digital Laboratory Platforms
One of the most important trends shaping the Liquid Handling System Market is the integration of liquid handlers with robotics and digital laboratory technologies.
Instead of operating as isolated instruments, modern liquid handling systems can be connected with robotic arms, thermal cyclers, plate readers, imaging systems, laboratory information systems, and other equipment.
This creates more connected workflows in which samples can move through several stages with limited human intervention.
Kings Research highlights the growing integration of multiple automation platforms as laboratories seek to create end-to-end workflows. In June 2024, Beckman Coulter Life Sciences launched the Biomek Echo One System, combining the Echo 525 Acoustic Liquid Handler with the Biomek i7 Hybrid Workstation for applications including NGS library preparation and DNA assembly.
Such systems demonstrate how laboratory automation is moving beyond individual instruments toward interconnected platforms.
Artificial Intelligence Brings Intelligence to Laboratory Automation
Artificial intelligence is also beginning to influence liquid handling technology. AI-enabled systems can help laboratories optimize workflows, monitor performance, identify anomalies, and analyze operational data.
In January 2025, Tecan introduced Veya, a liquid handling platform featuring AI-enhanced automation, prebuilt workflows, and real-time analytics. The system is designed to support multiomics workflows while improving monitoring and scalability.
AI can potentially make laboratory automation more adaptable. Instead of simply following a fixed sequence, intelligent systems can use data to identify patterns and support improved workflow management.
This development is particularly relevant as laboratories become more digital. Future liquid handling platforms are likely to become increasingly connected to laboratory software, data-management systems, and automated decision-support tools.
Accuracy and Precision Remain Critical Challenges
Despite rapid technological development, maintaining pipetting accuracy and precision remains one of the major challenges facing the market.
Liquid handling systems often work with very small volumes, meaning that even minor dispensing variations can affect experimental outcomes. This makes routine calibration and performance verification essential.
In April 2024, Hamilton and CSEM introduced VeriPlate, a quality-control system designed to verify pipetting performance in automated liquid handling workstations. The system combines microfluidic technology with optical image analysis to support routine verification.
These developments highlight an important point about laboratory automation: automation alone is not enough. Laboratories also need reliable quality-control systems to ensure that automated equipment continues to perform within required specifications.
North America Maintains a Strong Market Position
North America accounted for 36.21% of the global liquid handling system market in 2024, representing approximately USD 1,713.3 million.
The region benefits from established pharmaceutical and biotechnology industries, advanced laboratory infrastructure, strong research spending, and early adoption of laboratory automation.
The United States, in particular, has a large ecosystem of pharmaceutical companies, biotechnology startups, academic institutions, contract research organizations, and diagnostic laboratories.
These organizations increasingly require high-throughput laboratory systems capable of supporting complex research programs.
Meanwhile, investment in healthcare digitization and biotechnology infrastructure is helping create additional opportunities for laboratory automation technologies.
Asia Pacific Emerges as a High-Growth Region
While North America currently holds the largest regional share, Asia Pacific is expected to record the fastest growth, with a projected CAGR of 6.17% between 2025 and 2032. The regional market is forecast to reach approximately USD 1,559.2 million by 2032.
Countries such as China, India, Japan, and South Korea are expanding their pharmaceutical, biotechnology, diagnostics, and research capabilities.
The development of biopharmaceutical manufacturing facilities is another important factor. In June 2025, WuXi Biologics began construction of a new commercial biomanufacturing facility in Chengdu, China. Expanding biomanufacturing capacity increases the need for reliable sample preparation, quality control, and laboratory automation technologies.
For India, growing pharmaceutical research, biotechnology development, clinical research, and diagnostic capabilities could create further demand for liquid handling systems over the coming years.
Recent Product Developments Strengthen Market Competition
Competition in the liquid handling system industry is increasingly centered on precision, automation, connectivity, and ease of use.
In May 2025, MGI launched the PrepALL platform, a compact liquid handling system designed for applications including nucleic acid extraction, sample preparation, and NGS library construction. The system incorporates Smart 8 technology and open API integration.
In March 2025, Technobis launched DoseALL, an automated liquid dosing module designed for chemical synthesis research and development. The system features independently controlled syringes and is designed to integrate with the company’s ReactALL reactor system.
These developments illustrate how manufacturers are moving toward systems that are not only accurate but also modular, connected, and adaptable to different laboratory environments.
Competitive Landscape
The global Liquid Handling System Market includes major laboratory equipment manufacturers, life sciences companies, automation specialists, and laboratory technology providers.
Key companies identified by Kings Research include Thermo Fisher Scientific Inc., Hamilton Company, Tecan Trading AG, Agilent Technologies, Inc., Danaher Corporation, Eppendorf SE, Bio-Rad Laboratories, Inc., SPT Labtech Ltd, Gilson Incorporated, Sartorius AG, Beckman Coulter, Inc., Aurora Biomed Inc., 3CR Bioscience Ltd, Endress+Hauser, and INTEGRA Biosciences AG.
These companies are investing in automated workstations, intelligent software, robotic integration, precision dispensing, and application-specific platforms.
Partnerships are also helping connect laboratory instruments with specialized assays and workflows. In October 2024, BD and Hamilton collaborated on robotics-compatible reagent kits integrating BD’s OMICS-One XT WTA Assay with Hamilton’s Microlab NGS STAR liquid handling platform.
The Future of Laboratory Liquid Handling
The future of the Liquid Handling System Market will depend on how effectively manufacturers combine precision engineering with automation, software, robotics, and artificial intelligence.
The market is expected to reach USD 7,131.7 million by 2032, compared with USD 4,731.7 million in 2024.
Future systems are likely to become more compact, intelligent, connected, and easier to integrate with existing laboratory infrastructure. Instead of simply automating pipetting, liquid handling platforms are increasingly becoming part of broader laboratory automation ecosystems.
The growing use of genomics, personalized medicine, biologics, high-throughput screening, and molecular diagnostics will continue to create demand for precise sample processing.
At the same time, laboratories will place greater emphasis on data integrity, traceability, regulatory compliance, cybersecurity, and equipment validation.
Conclusion
The Liquid Handling System Market is evolving alongside the broader transformation of pharmaceutical, biotechnology, and healthcare laboratories. What was once primarily a manual pipetting task is increasingly becoming a sophisticated, digitally connected process involving robotics, automation, software, and artificial intelligence.
With the global market projected to increase from USD 4,731.7 million in 2024 to USD 7,131.7 million by 2032, liquid handling technology is expected to remain an important component of modern laboratory infrastructure.
Automated systems are gaining traction because they can help laboratories manage growing sample volumes while improving consistency and reducing repetitive manual work. Drug discovery, genomics, cancer research, clinical diagnostics, and biopharmaceutical development are all creating opportunities for advanced liquid handling technologies.
North America currently represents the largest regional market, while Asia Pacific is expected to experience the fastest growth through 2032. Meanwhile, innovations in AI-enabled automation, robotic integration, real-time analytics, and precision verification are gradually changing what laboratories expect from liquid handling equipment.
As research becomes more data-intensive and laboratories continue moving toward connected, high-throughput environments, liquid handling systems will play an increasingly important role in improving laboratory efficiency, reproducibility, and the speed at which scientific discoveries move from research to real-world healthcare applications.
